Kibiki, Gibson S

High-dose rifampicin, moxifloxacin, and SQ109 for treating tuberculosis: a multi-arm, multi-stage randomised controlled trial

Boeree, M. J., Heinrich, N., Aarnoutse, R., Diacon, A. H., Dawson, R., Rehal, S., Kibiki, G. S., Churchyard, G., Sanne, I., Ntinginya, N. E., et al. (2017) · The Lancet Infectious Diseases

Tuberculosis Research and EpidemiologyInfectious Diseases and Tuberculosis

Cited by 379

Epidemiology of subpatent Plasmodium falciparum infection: implications for detection of hotspots with imperfect diagnostics

Mosha, J. F., Sturrock, H. J., Greenhouse, B., Greenwood, B., Sutherland, C. J., Gadalla, N., Atwal, S., Drakeley, C., Kibiki, G., Bousema, T., et al. (2013) · Malaria Journal

Malaria Research and ControlBird parasitology and diseases

Cited by 114

Feasibility of Real Time Medication Monitoring Among HIV Infected and TB Patients in a Resource-Limited Setting

de Sumari-de Boer, I. M., van den Boogaard, J., Ngowi, K. M., Semvua, H. H., Kiwango, K. W., Aarnoutse, R. E., Nieuwkerk, P. T., & Kibiki, G. S. (2016) · AIDS and Behavior

HIV/AIDS Research and InterventionsMedication Adherence and Compliance

Cited by 40